Guess which four ASX 300 shares were just re-rated by top brokers

Leading brokers have re-evaluated the prospects for these ASX 300 companies.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Four S&P/ASX 300 Index (ASX: XKO) shares were just re-rated by top brokers.

One operates in the credit-impaired consumer debt segment.

The second is a biopharmaceutical company.

The third provides vehicle fleet leasing, fleet management, and diversified financial services.

And the fourth is a New Zealand-based building and materials company.

Any guesses?

Keep those in mind.

(Broker figures courtesy of The Australian.)

Two brokers analysing stocks.

Image source: Getty Images

ASX 300 shares getting re-rated

The first ASX 300 share getting re-rated is Credit Corp Group Ltd (ASX: CCP)

The Credit Corp share price is up 4.0% in intraday trading at $15.47 a share. That sees the stock up more than 23% over six months.

And Macquarie believes it's still undervalued after that strong run. The broker raised Credit Corp to an 'outperform' rating with an $18.32 price target. That represents a 19% potential upside from current levels.

Credit Corp shares also have a strong history of delivering reliable passive income. Over the past 12 months, the company has paid out 62 cents a share in fully franked dividends. That equates to a current trailing yield of 4.0%.

Which brings us to the second ASX 300 share getting a broker re-rate today, Neuren Pharmaceuticals Ltd (ASX: NEU).

The Neuren Pharmaceuticals share price is up 6.1% in intraday trading at $20.22 a share. Shares are now up a whopping 42% over six months.

And according to JP Morgan it still looks like a bargain at these levels.

The broker gave Neuren an 'overweight' rating and a $23.60 price target, representing a potential 17% upside from current levels. The company does not pay dividends at this time.

Also getting re-rated

Also getting re-rated today is ASX 300 share FleetPartners Group Ltd (ASX: FPR).

The FleetPartners share price is down 4.1% today at $3.31 a share. However, shares remain up 19% over six months.

And Morgan Stanley thinks today's sell-down is likely misguided. The broker increased its price target for FleetPartners by 22% to $3.90 a share and maintained its 'overweight' rating. That represents a potential 18% upside from current levels.

FleetPartners shares last delivered dividends in 2018.

Rounding off the list, the fourth ASX 300 share getting re-rated today is Fletcher Building Ltd (ASX: FBU).

(Did you guess all four?)

The Fletcher Building share price is down 3.0% today at $2.79 a share. The stock has tumbled 35% over six months.

Fortunately, Morgan Stanley believes the worst of the pain should be over.

While the broker cut its price target by 23% to $2.84 a share, Morgan Stanley maintained its 'equal-weight' rating.

Fletcher Buildings suspended its interim dividend payment for FY 2024 due to challenging trading conditions.

JPMorgan Chase is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended JPMorgan Chase and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

a mature but cool older woman holds a watering can and tends to a healthy green plant growing up the wall in her house.
Broker Notes

Bell Potter just initiated coverage on this ASX utilities stock with a buy recommendation

This under the radar company could be worth watching.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

3 reasons to buy QBE shares today

A leading analyst expects QBE shares to outperform. Let’s see why.

Read more »

Broker looking at the share price.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

man looks at phone while disappointed
Broker Notes

What are analysts saying about ResMed, Downer, and Nuix shares?

They have given their verdicts on these shares. Are they bullish or bearish? Here's what you need to know.

Read more »

A U.S. Naval Ship (DDG) enters Sydney harbour.
Broker Notes

Why it's not too late to buy this surging ASX All Ords defence stock

A top broker expects more outperformance from this rocketing ASX defence stock.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Brainchip, CAR Group, and Endeavour shares

Let's see what analysts think about these shares this week.

Read more »

Business people discussing project on digital tablet.
Broker Notes

Buy, hold, sell: Life360, Magellan, and QBE shares

Are analysts bullish or bearish on these names? Let's find out.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

2 ASX shares highly recommended to buy: Experts

These ASX shares are some of the most positively-rated businesses on the ASX.

Read more »